Sign in
Taking people in United StatesNo phase

Registry following patients treated with stereotactic radiation for tumors and other conditions

Tracks patients receiving stereotactic radiation for tumors, brain vessel malformations, or nerve pain.

Key facts

Who runs it
The Radiosurgery Society
Where
Brunswick, Chattanooga, Colorado Springs, Danville, Detroit, Egg Harbor, Huntington, Miami, Philadelphia, Pottstown, Red Bank, The Bronx, and Toms River, United StatesSee the 13 sites
Trial code
Registry title
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Status
Recruiting
People taking part
50,000 people, planned
Started
Mar 2012
Expected to end
Dec 2030
Type of study
Observational
Treatments tested
  • SRS/SBRT
Record updated
19 September 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for people with benign or malignant tumors or other conditions that doctors consider treatable with stereotactic radiosurgery (SRS) or stereotactic body radiotherapy (SBRT).

Sex
All sexes can join.
Disease stage
Benign or malignant tumors, or other conditions considered treatable by stereotactic radiosurgery or stereotactic body radiotherapy.

Main reasons for not taking part

  • Not willing to sign the informed consent document or to agree verbally to take part
  • Declines to take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
  • Willingness to sign an Informed Consent Document or verbally agree to participation

Who cannot take part

  • There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Where in United States

  • Southeast Georgia Health SystemBrunswick, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Cyberknife at ErlangerChattanooga, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Penrose Cancer CenterColorado Springs, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Geisinger Health SystemDanville, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Henry Ford Health SystemDetroit, United StatesContact: Celina Kirsch, P.A.Taking people
  • AtlantiCare Regional Medical Center and AtlantiCare Cancer Care InstituteEgg Harbor, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • St. Mary's Medical CenterHuntington, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Sylvester Comprehensive Cancer Center, University of MiamiMiami, United StatesContact: Gregory A Azzam, MDTaking people
  • Philadelphia CyberKnifePhiladelphia, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Pottstown Memorial Medical CenterPottstown, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Riverview Medical CenterRed Bank, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • Montefiore Medical CenterThe Bronx, United StatesContact: Jan Jenkins, RNEnrolling by invitation
  • NJ Cyberknife at Community Medical CenterToms River, United StatesContact: Jan Jenkins, RNEnrolling by invitation

About the trial

What the trial wants to find out

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

The group in the trial

  • Patients being treated by SRS/SBRT

    Patients with a condition being considered for treatment by SRS/SBRT

    Treatment: SRS/SBRT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Multi-Institution Registry of SRS/SBRT Procedures
Plain-language title
Registry following patients treated with stereotactic radiation for tumors and other conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
19 September 2024